ADC Bio to build Welsh manufacturing site on back of antibody-drug demand
UK-based processing tech provider ADC Biotechnology will build a $10m plant for the GMP manufacture of antibody-drug conjugates (ADCs).
UK-based processing tech provider ADC Biotechnology will build a $10m plant for the GMP manufacture of antibody-drug conjugates (ADCs).
M+W has been contracted to build a £55m ($84m) manufacturing site that will support cell and gene therapy developers by the UK Government project, Cell Therapy Catapult.
Probiodrug has selected German CMO Rentschler to develop its Alzheimer’s monoclonal antibody candidate.